Compare CAC & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CAC | QSI |
|---|---|---|
| Founded | 1875 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.2M | 161.8M |
| IPO Year | 1996 | N/A |
| Metric | CAC | QSI |
|---|---|---|
| Price | $49.00 | $0.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $45.50 | $1.00 |
| AVG Volume (30 Days) | 76.2K | ★ 2.9M |
| Earning Date | 04-28-2026 | 05-14-2026 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | ★ 6.08 | N/A |
| EPS | ★ 3.84 | N/A |
| Revenue | ★ $41,739,000.00 | N/A |
| Revenue This Year | $19.15 | N/A |
| Revenue Next Year | $6.05 | $618.07 |
| P/E Ratio | $12.56 | ★ N/A |
| Revenue Growth | ★ 16.96 | N/A |
| 52 Week Low | $34.53 | $0.72 |
| 52 Week High | $51.57 | $3.10 |
| Indicator | CAC | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 64.93 | 33.24 |
| Support Level | $41.94 | N/A |
| Resistance Level | $51.36 | $1.11 |
| Average True Range (ATR) | 1.08 | 0.05 |
| MACD | 0.37 | -0.01 |
| Stochastic Oscillator | 100.00 | 8.34 |
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.